Obese diabetes patients gain HbA1C benefit from bypass liner

10/1/2013 | Medscape (free registration)

A small study presented at the European Association for the Study of Diabetes meeting revealed severely obese type 2 diabetes patients who used EndoBarrier, a duodenal-jejunal bypass liner, showed reduced HbA1C levels, dropping from 8.5% to 7.5% at one year. In addition, patients reduced their body weight by an average of 10% and experienced improvements in fasting glucose levels and systolic blood pressure.

View Full Article in:

Medscape (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Deputy Director, Marketing
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Director of Operations - GBS
Mayo Clinic
MN
Director of Actuarial Services, Government Programs
PacificSource
OR
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC